Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice.

ABSTRACT: There has been much progress in treating kidney cancer, with several new drugs being approved over the last few years [...].

SUBMITTER: Wanniarachchi HI 

PROVIDER: S-EPMC11898701 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature